Literature DB >> 10340048

Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.

T Yamada1, K Shinohara, K Takeda, N Kameda, K Katsuki, K Ariyoshi, T Kamei.   

Abstract

We report a rare complication of a secondary malignant solid tumor in two patients with non-Hodgkin's malignant lymphoma who developed lung adenocarcinoma after treatments with combination chemotherapies. The first was a case of primary malignant lymphoma of the cervical spinal cord which had been previously treated with radiation to the spinal lesion and combination chemotherapies and entered complete remission. The patient was further treated for relapse with autologous bone marrow transplantation preconditioned with high-dose chemotherapy. Lung adenocarcinoma developed 5.5 years after the initial diagnosis. The second case of malignant lymphoma of lymph nodes did not respond to conventional combination chemotherapies and did not enter remission. Lung adenocarcinoma developed 1 year after the initial diagnosis. The two patients died of lung carcinoma. The clinical profiles of these cases are presented and the causal relationship of primary malignant neoplasms to the second malignant neoplasms is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340048     DOI: 10.1093/jjco/29.4.226

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Pleomorphic carcinoma of the lung with mediastinal extension following malignant lymphoma: report of a case.

Authors:  Takahiro Nakajima; Toshihiko Iizasa; Akira Iyoda; Kenzo Hiroshima; Kazuhiro Yasufuku; Masako Chiyo; Takashi Anayama; Hidemi Suzuki; Kiyoshi Shibuya; Hidemi Ohwada; Takehiko Fujisawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.

Authors:  Manoela Tiago; Edson Mendes de Oliveira; Carla Abdo Brohem; Paula Comune Pennacchi; Rafael Duarte Paes; Raquel Brandão Haga; Ana Campa; Silvia Berlanga de Moraes Barros; Keiran S Smalley; Silvya Stuchi Maria-Engler
Journal:  Tissue Eng Part A       Date:  2014-03-25       Impact factor: 3.845

Review 3.  Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

Authors:  Frank Peinemann; Lesley A Smith; Carmen Bartel
Journal:  Cochrane Database Syst Rev       Date:  2013-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.